Skip to main content
FUL
NYSE Industrial Applications And Services

H.B. Fuller Amends Credit Agreement, Upsizes Revolver to $800M, Extends Maturity to 2031, and Terminates $2.1B Bridge Facility

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
8
Price
$55.89
Mkt Cap
$3.006B
52W Low
$48.71
52W High
$68.63
52W Position info
15% above low
Off High info
19% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

FUL is trading near its 52-week low of $48.71 (15% above the low) on light trading volume (0.3× avg).

Summary

H.B. Fuller amended its credit agreement, upsizing its revolving facility to $800M, extending maturity to 2031, and lowering pricing. It also terminated the $2.1B bridge facility arranged for the Advanced Medical Solutions acquisition, with no amounts drawn.


Key Events · Financing and Capital Events · FUL

  • Credit Agreement Amended and Upsized

    Amendment No. 3 refinances existing term A and revolving loans with a new $420M term A loan and an $800M revolving facility (up from $700M), extends maturity to July 17, 2031, and reduces interest rate margins by 25 basis points.

  • Bridge Facility Terminated Undrawn

    The $2.087B Secured Bridge Credit Agreement, dated June 25, 2026, was terminated with no amounts outstanding. The bridge was arranged as a backstop for the Advanced Medical Solutions acquisition.

  • Amsterdam Acquisition Debt Basket Added

    The credit agreement was amended to permit up to $1B in debt under an Amsterdam Unsecured Bridge Facility or Amsterdam Permanent Financing, directly supporting the pending £715M acquisition of Advanced Medical Solutions.

  • Improved Pricing and Extended Maturity

    The new term A and revolving loans benefit from a 25 bps reduction in interest rate margins and a maturity extension to 2031, reducing near-term refinancing risk and lowering borrowing costs.


Analysis · FUL · Industrial Applications And Services

H.B. Fuller refinanced its credit agreement, replacing existing term A and revolving loans with a new $420M term A loan and an $800M revolving facility (up from $700M). The maturity was pushed to 2031 and pricing improved by 25 bps. The company also terminated the $2.087B bridge loan it had arranged just weeks ago to fund the £715M Advanced Medical Solutions acquisition — no amounts were drawn, signaling the bridge was a backstop. The amended credit agreement now explicitly permits up to $1B in debt for the Amsterdam acquisition, clearing the path for permanent financing. This is a significant capital structure refresh that supports the transformative acquisition while reducing near-term refinancing risk.

At the time of this filing, FUL was trading at $55.89 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $48.71 to $68.63. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FUL - Latest Insights

FUL
Jun 26, 2026, 4:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $63.25
Real-time Price: $55.89 info
Change: -$7.36 (-12%) info
Market Cap: $3.006B info
FUL
Jun 25, 2026, 3:11 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $60.99
Real-time Price: $55.89 info
Change: -$5.10 (-8%) info
Market Cap: $3.006B info
FUL
Jun 25, 2026, 3:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $60.74
Real-time Price: $55.89 info
Change: -$4.85 (-8%) info
Market Cap: $3.006B info
FUL
Jun 25, 2026, 8:28 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $59.27
Real-time Price: $55.89 info
Change: -$3.38 (-6%) info
Market Cap: $3.006B info
FUL
Jun 25, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $62.75
Real-time Price: $55.89 info
Change: -$6.86 (-11%) info
Market Cap: $3.006B info